Somer Baburek, MBA

Hera Biotech is an early-stage, women's health company, focused on commercializing a minimally invasive diagnostic for endometriosis. My Role in the company is as follows: • Develop/Draft key company documents, including business plan, financial projections and executive summary. • Manage relationships with key opinion leaders, stake holders and investors • Raise necessary capital to fund business activities and commercial development • Negotiate all contractual relationships • Report to, and work with, the board of directors to ensure all expenditures and activities are in alignment with organizational goals and timelines

• Conduct due diligence on companies seeking funding • Evaluate technology potential, regulatory strategy, clinical strategy, go to market strategy, assumptions and company leadership • Evaluate end markets, adoption rates and acquisition potential • Participate in term sheet discussions • Coach appropriate leadership in investment companies • Provide board representation for the fund • Assist in quarterly fund report composition • Serve as clinical, regulatory and strategy resource to fund companies and act as liason between company leadership and managing partners • Participate in decision making on changes in strategyand/or leadership in fund companies • Serve an active role in fund comapnies, when necessary (see Santalis)

• Draft/Review/Amend/Negotiate key clinical documents, to include: Clinical or Master Trial Agreements, Study Work Orders, Clinical Budgets, Protocols, Investigator Brochures, biostatistical summaries and Clinical Study Reports. • Manage all clinical vendors, to include: clinical sites, eCRF vendors, CROs, medical writers, IRB/HREC, randomization, clinical site monitors. • Oversee all aspects of clinical trial execution/operation, to include: regulatory filings, site/vendor selection, study timelines, routine monitoring, real time data review, IRB submissions, study closeout activities. • Manage the Santalis clinical team and all external clinical consultants. • Work directly with executive management to ensure all clinical activities are in alignment with organizational goals and timelines • Served as the interim COO for a period of 18 months

- Managed Santalis' prescription drug development indications in the clinic. - Oversaw business development consultants and commercial development programs on the OTC/cosmetic side of the business. - Collaborated with formulation chemists and commercial manufacturers to optimize formulations for drug delivery and scale up ease. - Developed & implemented internal tracking systems including clinical costing by site and patient responses by visit. - Implemented formal clinical processes, to include: SOPs, SOP review process, both electronic and hard copy trial master filing system. - Managed up to 4 direct reports.

- Lead the team responsible for product development (formulation to commercialization). - Supervised the entire clinical trial process from synopsis and protocol development, study monitoring and generating bio-statistical summaries at the conclusion of the study. - Managed communication and project timelines with external consultants and licensing partners. - Oversaw and assisted in the due diligence process, transfer and successful launch of a product line externally licensed by the largest dermatology company in the world.

Claresta Solutions is a medical technology company focused on the field of obstetrics.

BBA: Entrepreneurship & Business Development Graduated Magna Cum Laude; 3.9 GPA Winner of the 2013 Center for Innovation, Technology & Entrepreneruship (CITE) competition Inventor of the 2013 CITE competition winning technology (See Claresta Solutions)